Clinical Trial Update: A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas [Phase 1]

View source ↗

Summary

A Phase I trial evaluating gemcitabine with radiation therapy for locally advanced unresectable pancreatic cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms
• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastrointestinal Neoplasms, Pancreatic Neoplasms | Phase 1 | Status: COMPLETED